Proxy Votes Now

Home › Funds › PENN SERIES FUNDS INC › Small Cap Growth Fund

Small Cap Growth Fund proxy voting record 2025-2026

Fund family: PENN SERIES FUNDS INC · Filed by PENN SERIES FUNDS INC (CIK 702340) · SEC series S000006737

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 1,032 with, 8 against, 0 abstentions (not counted as with management); 3 items carried no recommendation. Shareholder proposals: 5 FOR, 4 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with PENN SERIES FUNDS INC as a whole

The same two figures as PENN SERIES FUNDS INC’s manager page (42,846 ballot items across 19 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsPENN SERIES FUNDS INCItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)94.9%99493.7%37,596
Backed environmental and social shareholder proposals at US companiesn/a110.0%422

Where this fund voted differently from most PENN SERIES FUNDS INC funds

Each ballot item this fund voted is set against the votes of the other PENN SERIES FUNDS INC funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most PENN SERIES FUNDS INC funds on 3 items (2.2% of the 135 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost PENN SERIES FUNDS INC fundsMgmtResult
Globus Medical, Inc.2026-06-03Approval of an amendment to the Globus Medical, Inc. 2021 Equity Incentive Plan to increase the number of authorized shares thereunder by 1,000,000.ForAGAINST — 4 of 4 PENN SERIES FUNDS INC fundsForApproved, 76.6% support
Revolution Medicines, Inc.2026-06-18To elect two Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until his successor is elected: Alexis BorisyWithholdFOR — 2 of 3 PENN SERIES FUNDS INC fundsAgainstPassed (calculated), 79.1% support
Praxis Precision Medicines, Inc.2026-06-10To elect the Class III Directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: William YoungForWITHHOLD — 2 of 3 PENN SERIES FUNDS INC fundsForPassed (calculated), 85.5% support

Download all 3 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 81.1% of this fund’s 1,040 such votes could be given a sector; the other 197 (18.9%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Health Care22510.4%
Industrials18110.6%
Consumer Discretionary13510.7%
Technology11000.0%
Finance9411.1%
Real Estate2600.0%
Energy2100.0%
Miscellaneous1600.0%
Telecommunications1400.0%
Utilities1417.1%
Consumer Staples700.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections6890
Audit-related1250
Say-on-Pay1110
Compensation490
Corporate Governance407
Capital Structure160
Extraordinary Transactions140
Shareholder Rights and Defenses50
Other20
Environment or Climate11

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Glaukos CorporationMay 28, 2026$4M40
Casey's General Stores, Inc.September 3, 2025$2M151
Ligand Pharmaceuticals IncorporatedJune 5, 2026$2M110
SS&C Technologies Holdings, Inc.May 20, 2026$2M60
Crown Holdings, Inc.April 30, 2026$2M131
Cboe Global Markets, Inc.May 14, 2026$2M151
Sensient Technologies CorporationApril 23, 2026$2M110
OSI Systems, Inc.December 11, 2025$2M80

Notable votes against management

MeetingCompanyProposalFundMgmt
September 3, 2025Casey's General Stores, Inc.Shareholder proposal regarding Scope 3 greenhouse gas reduction targets. Shareholder proposalAgainstFor
April 30, 2026Crown Holdings, Inc.Consideration of a Shareholder proposal regarding Shareholder right to act by written consent. Shareholder proposalForAgainst
May 14, 2026Cboe Global Markets, Inc.Stockholder proposal regarding shareholder right to act by written consent. Shareholder proposalForAgainst
May 13, 2026ICU Medical, Inc.To approve, on an advisory basis, a stockholder proposal to establish a 10% stockholder special meeting right. Shareholder proposalAgainstFor
April 30, 2026NRG Energy, Inc.To vote on a stockholder proposal to give shareholders the ability to call for a special shareholder meeting, if properly presented at the meeting. Shareholder proposalForAgainst
May 6, 2026Entegris, Inc.Stockholder Proposal: Providing stockholders the right to call special meetings of stockholders. Shareholder proposalForAgainst
May 6, 2026Premium Brands Holdings CorporationSP 1: Adopt and Disclose Policy to Review and Disclose Findings for Directors With Low Vote Support Shareholder proposalAgainstFor
May 6, 2026Premium Brands Holdings CorporationSP 2: Adopt and Disclose Policy to Regularly Disclose Director Voting Records Shareholder proposalAgainstFor

Contested meetings

Meetings with a proxy contest or competing nominees (2 in 2025-2026), and how the fund voted the items on its ballot.

Search this fund’s votes by company

1,053 ballot items at 129 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, Small Cap Growth Fund voted at 129 shareholder meetings of 125 companies, on 1,053 ballot items in all. Where management made a recommendation, the fund followed it on 99.2% of the items and voted against it 8 times. Its most frequent area of disagreement was corporate governance (7 of its votes against management). It voted on 9 shareholder proposals. It voted FOR the board's own proposals more often than PENN SERIES FUNDS INC's funds as a whole (94.9% against 93.7%). It voted differently from most PENN SERIES FUNDS INC funds on 3 items. 2 of its meetings were contested.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of PENN SERIES FUNDS INC’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.